Quinta Analytica Information

Founded in 1997 and based in Prague, QUINTA-ANALYTICA s.r.o. is one of the biggest independent companies in Central and Eastern Europe specialising in commercial services for pharmaceutical, biotechnology and generic drug industries as a contract research organization (CRO). The main domains are pharmacokinetics and BA/BE clinical studies, bioanalytics, drug analysis including method development and transfer, batch quality control release, stability studies, analytics in inhalation antiasthmatics, peptides and proteins. QUINTA-ANALYTICA is regularly inspected by European agencies represented in Czech Republic by State Institute for Drug Control (SUKL) and has also successfully passed through several audits of the U.S Food and Drug Administration. QUINTA-ANALYTICA consists of six divisions, the biggest is the Pharmaceutical Analysis and Quality Control Division. R&D Division develops methods for pharmaceutical analyses. Bioanalytical Division analyzes samples from pharmacokinetics/toxicokinetics and bioequivalences studies, including pharmacology and biostatistics. The company also has 2 in-house Clinical Units at its own facility. The Units are used for clinical studies according to the GCP guidelines. The youngest professional division - Department of Biophamaceuticals - focuses on analysis of biological drugs, in particular proteins and peptides. QUINTA-ANALYTICA employs 130 people, with one half working on pharmaceutical analysis and quality control. In 2015, the company´s sales reached 256 million CZK.